Mulya.ai
Ticker
UHS
Scenario
Key Inputs
Revenue est.?Analysttaper yr4
OP margin est.?Analyst
Reinvestment est.?projected
R&D capitalizedNo
Leases factoredNo
Key Assumptions
WACC ?9.5%
ERP ?4.5%
Risk-free rate ?4.1%
Beta (blended) ?1.261
Beta (levered) ?1.698
Terminal OM% ?17.5%
Segment conc. ?57% dominant
Terminal growth ?4.1%
Bond rating ?AAA · 0.60%
ROIC option ?Opt 4 · 20.3%
Prob of failure ?0.0%
Pipeline validated · 2026-05-17

UHS · Universal Health Services, Inc.

$176.702026-05-17
Sector: Healthcare; Industry: Medical - Care Facilities; Sub-Industry: Health Care Facilities

Intrinsic Value Range Comparison · Mulya.ai

Bull
$862
+387.9% vs market
Base · active
$560
+217.0% vs market
Bear
$543
+207.2% vs market
Mulya.ai vs Analyst IV Comparison?
Market $177
Median $242
Bear $543
Base $560
Bull $862
Market Price $177
Mulya.ai Base $560
Analysts Median $242
Mulya.ai IV range ($543 · $862)
Analysts Range ($219 · $274)
Fundamentals · historical + forward · base
italics = DCF projection
PeriodRevenueRev Gr ?Ops M% ?Tax Rate ?NOPAT ?
Reinvest ?
FCFF ?WACC% ?PV FCFF ?ROIC ?Inv. Cap ?EPS ?P/E
2021.Q4$12.6B10.8%23.6%$1.0B−$350MM$691MM8.6%10.2%$10.2B$15.38
2022.Q4$13.4B6.0%7.5%24.2%$761MM−$417MM$344MM9.2%7.3%$10.7B$10.48
2023.Q4$14.3B6.6%8.2%23.5%$899MM−$218MM$681MM8.9%8.3%$11.0B$11.14
2024.Q4$15.8B10.8%10.6%22.4%$1.3B−$416MM$890MM9.5%11.8%$11.1B$17.72
2025.Q4$17.4B9.7%11.5%23.4%$1.5B−$563MM$965MM9.4%13.1%$12.2B$23.105.7
italics below = DCF projection · 10yr Rev CAGR: 4.7%
2026.Q4$18.5B+6.4%11.5%23.0%$1.6B−$513MM$1.1B9.4%$1.0B13.1%$12.7B$25.327.0
2027.Q4$19.4B+4.9%12.1%22.7%$1.8B−$474MM$1.3B9.4%$1.1B14.0%$13.2B$28.166.3
2028.Q4$20.3B+4.9%12.8%22.4%$2.0B−$565MM$1.5B9.3%$1.1B15.0%$13.8B$31.465.6
2029.Q4$21.3B+4.8%12.8%22.0%$2.1B−$504MM$1.6B9.2%$1.1B15.2%$14.3B$33.105.3
2030.Q4$22.3B+4.7%12.8%21.7%$2.2B−$553MM$1.7B9.1%$1.1B15.4%$14.8B$34.795.1
Term. Yr+$28.7B4.1%17.5%20.0%$4.0B−$812MM$3.2B8.6%$29.9B20.3%
Active scenario IV: $560 (+217.0% vs market)